recombinant human interleukin-21

BIOLOGICAL2 trials

Sponsors

ZymoGenetics, NCIC Clinical Trials Group

Conditions

Kidney NeoplasmsMelanomaMelanoma (Skin)Metastases

Phase 1

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

CompletedNCT00095108

ZymoGeneticsKidney Neoplasms, Melanoma, Metastases

Start: 2004-05-31End: 2007-01-31Updated: 2009-03-09

Phase 2

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

CompletedNCT00514085

NCIC Clinical Trials GroupMelanoma (Skin)

Start: 2007-12-13End: 2012-07-04Updated: 2023-08-04